Product search
Sort by
Search results
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
Donor Plasma with Vitamin K antagonists (Warfarin-Sodium, Coumadin)
For all in vitro analyses that require vitamin K antagonist plasma.
BIOPHEN Factor IX (1)
Assay proposed for the measurement of factor IX activity in research applications.
CRYOcheck Factor VIII Inhibitor Kit, frozen
The CE marked kit is ideal for laboratories seeking to standardize sample preparation to limit variability in their MNBA. Each kit contains five vial sets—enough to prepare five patient samples—including positive and negative FVIII inhibitor controls Excellent repeatability and reproducibility; suitable for multi-center clinical studies Excellent linearity across a broad reportable range Convenient frozen format—ready to use within minutes, no reconstitution errors Further information available -> here Please find the safety data sheet for the controls included in the kit by clicking the MSDS download button below. Please find the safety data sheet for the included component IB-PNP here . Please find the safety data sheet for the included component IB-BSA here .
Fibrinogen, porcine
Fibrinogen, porcine, purified
Bivalirudin (Angiox®) Plasma Control
Quality control of clotting assays proposed for measuring bivalirudin concentrations in plasma (especially ref. CK002K, CK002L and 220202).
Bivalirudin (Angiox®) Plasma Calibrator
Calibrating the assays of bivalirudin using anti-IIa methods, especially with HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) or BIOPHEN DTI (ref. 220202).
CoaChrom™ Severe Abnormal Control Plasma
Severe Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
CoaChrom™ Moderate Abnormal Control Plasma
Moderate Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
Aprotinin
Aprotinin can be used in any application where inhibition of its targeted proteases is needed. Current uses include protein isolation, removal of reactive proteases through solid phase, inhibition of undesired proteolytic activity in laboratory assays, or other techniques; for blocking fibrinolytic activity in vitro; etc.